The Singapore Immunology Network (SIgN) was conceptualized in 2005 and established in 2006 by the Agency for Science, Technology and Research (A*STAR) with the aim of expanding and strengthening immunology research in Singapore. The Founding Chairman was Prof Philippe Kourilsky and the Founding Executive Director was Prof Lam Kong Peng.
In January 2008, a new 6,000m2 laboratory and office space in Immunos building at Biopolis was officially inaugurated as the home of SIgN.
SIgN is presently led by Professor Lam Kong Peng, Executive Director.
Mission and Objective
SIgN’s mission is to advance human immunology research, contribute scientific knowledge and make innovative discoveries to improve lives and further socio-economic growth. SIgN is committed to translate research findings into clinical and commercial applications, in partnership with clinics and industry.
SIgN is home to ~170 national and international researchers and support staff working under 14 renowned Principal Investigators under the directorship of Professor Lam Kong Peng. The current SIgN researcher groups may be broadly categorized into three main areas of focus: Immuno-Oncology, Immune Potential, Regulation & Ageing and Immuno-Pathology. Our researchers also have key interests and expertise in Inflammation, Immunotherapy, Aging, Allergy and Skin Disease.Our research activities are supported by a strong in-house cluster of cutting-edge technology platforms.
SIgN is committed to lead in immunology research and nurture research talents. At SIgN, all researchers can expect a stimulating environment that promotes analytical thinking, interdisciplinary collaboration and entrepreneurial spirit.